Diagnostic Imaging Market is expected to develop at a compound annual growth rate of 5.82% among 2022 and 2028. This increase can be driven by improvements in medical technology, a growth in continual ailment rates, a growing demand for early disorder detection, and improvements in international healthcare infrastructure.

Renub Research has lately published a report named “Diagnostic Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2028,” providing an exhaustive industry analysis comprising market share acumen. Furthermore, the report studies competitors and regions and the recent rise in the Diagnostic Imaging Market.

The diagnostic imaging market is growing and is anticipated to attain US$ 40.29 Billion via 2028

Diagnostic imaging technology produces exceptional images of internal organs and tissues, which enables healthcare professionals to make greater accurate diagnoses and enhance patient results.

Medical imaging has converted healthcare in the last 30 years by permitting early disease identity, improving medication, and improving patient outcomes. It is essential for evaluating and enhancing treatment plans, mainly for chronic ailments. Ultrasound technology is crucial for treating pregnant ladies. It additionally plays an important position in preventive medication and aids in detecting diseases like breast cancers early. Surgeons use medical imaging during surgical methods.

Chronic diseases are at the upward push globally, main to an increase in scientific imaging for identity. Artificial intelligence integration in imaging techniques has increased increase in the market. Also, sports activities medication is predicated heavily on imaging generation for correct and particular patient care.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=diagnostic-imaging-market-p.php

X-rays are a standard diagnostic imaging tool used in many medical settings

Interventional X-ray equipment, including C-arms and others, is driving the market’s growth due to the rise of image-guided surgeries. Furthermore, the ultrasound segment will expand during the forecast period due to increased ultrasonic applications. Recent advancements in ultrasound transducers have also enabled innovative ways to use ultrasound equipment for biomedical and cardiovascular imaging.

The orthopedic segment is currently dominating the global diagnostic imaging market

The orthopedics market is experiencing a surge in demand due to the aging population and a rise in accidents. Additionally, the market expansion is driven by the accessibility of advanced diagnostic tools. Meanwhile, the cardiovascular and cancer segment holds a substantial market share thanks to the increasing prevalence of these diseases, innovative technological advancements, and enhanced reimbursement policies.

The lion’s share of the diagnostic imaging market belongs to the hospital sector

The hospital industry is experiencing a significant boost due to its widespread use in public and private settings. This growth will continue as more technologically advanced hospitals with cutting-edge diagnostic imaging equipment are constructed. Additionally, the demand for diagnostic imaging treatments is increasing, leading to growth in private imaging facilities and diagnostic centers during the forecast period.

Related Reports

Lung Cancer Diagnostics Market https://www.renub.com/lung-cancer-diagnostics-market-p.php

Urinary Tract Infection Treatment market: https://www.renub.com/urinary-tract-infection-treatment-market-p.php

Molecular Diagnostics Market: https://www.renub.com/global-molecular-diagnostics-market-opportunities-and-future-forecast-414-p.php

Lung Cancer Screening Market: https://www.renub.com/lung-cancer-screening-market-p.php

North America dominates the diagnostic imaging market and is expected to maintain its position in the projected period

The United States contributes the largest share of the diagnostic imaging market due to increasing affordability rates among the general population, annual growth in diagnostic operations, and technological advancements. Over the projected period, the market is expected to expand, driven by well-established healthcare facilities, rising demand for better healthcare systems from the geriatric population, and the increasing prevalence of chronic illnesses. For instance, the American Cancer Society projected 1.9 million new cancer cases in the country in 2022. Additionally, market expansion is expected to be fueled by the prevalence of neurological disorders such as brain tumors.

Competitive Landscape

Leading contenders in the diagnostic imaging market include FUJIFILM VisualSonics Inc., Canon Medical Systems Corporation, Bruker, PerkinElmer Inc., Hitachi, Hologic, Radnet, and Koninklijke Philips.

Market Summary:

Product– The report analyses the diagnostic imaging market from six angles (X-ray, CT, Ultrasound, MRI, Nuclear Imaging, and Others).
Application– The Diagnostic Imaging Market is segmented into five perspectives according to Application (Orthopedics, Cardiovascular, Neurology, Pelvic & Abdomen, Oncology).
End-User- A report by Renub Research on the Diagnostic Imaging Market examines the topic from three perspectives (Hospitals, Diagnostic Centres, and Others).
Region- The Diagnostic Imaging Market by region is divided into five points of view (North America, Europe, Asia Pacific, South America, Middle East & Africa).
Key Players– Every significant player has been discussed from three perspectives (Overview, Recent Developments, and Revenue): FUJIFILM VisualSonics Inc., Canon Medical Systems Corporation, Bruker, PerkinElmer Inc., Hitachi, Hologic, Radnet, and Koninklijke Philips.

About the Company:

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.